Abiopharma

Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results

BD Receives FDA 510(k) Clearance for EnCorEnCompass™ Breast Biopsy and Tissue Removal System

Takeda to Hold Earnings Call for Fiscal Year 2025 3rd Quarter on January 29

Notification of cessation of securities - MSB

Notification regarding unquoted securities - MSB

CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm

Managing Director’s letter to shareholders

ResMed Inc. Daily Stock Update

Notification from cbdMD, Inc.

Biomerica, Inc. - Biomerica Reports Second Quarter Fiscal 2026 Financial Results